Clinical Trials Directory

Trials / Recruiting

RecruitingNCT06460805

axSEND: Exploring Immune and Microbiota Effects of a Partial Enteral Nutrition Diet in Axial Spondyloarthritis

axSEND: Exploring Immune and Microbiota Effects of a Partial Enteral Nutrition Diet in People With Axial Spondyloarthritis

Status
Recruiting
Phase
N/A
Study type
Interventional
Enrollment
62 (estimated)
Sponsor
NHS Greater Glasgow and Clyde · Academic / Other
Sex
All
Age
16 Years
Healthy volunteers
Accepted

Summary

People with axial spondyloarthritis (axSpA) often have intestinal inflammation and intestinal microbiome dysbiosis, with some similarities to Crohn's-like inflammatory bowel disease (IBD) gut inflammation. However, research has not addressed whether Partial Enteral Nutrition (PEN), a diet formed of a liquid formula and some solid whole foods, which is effective at inducing remission in IBD, may influence the dysbiotic microbiome and inflamed, hyperpermeable intestine of axSpA patients, and whether these changes may be accompanied by alterations in systemic markers of inflammation. Thus, there is a need to determine the effects of PEN on these aspects in axSpA patients. In this study, the investigators intend to trial a 2-week course (with optional additional 2-week extension) of a PEN diet in people with active axSpA disease. A group of healthy volunteers following the same diet will act as a control.

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTPartial enteral nutrition70% caloric intake from enteral nutrition formula and 30% caloric intake from a limited range of solid foods

Timeline

Start date
2024-04-25
Primary completion
2025-08-01
Completion
2025-08-01
First posted
2024-06-14
Last updated
2024-06-14

Locations

2 sites across 1 country: United Kingdom

Source: ClinicalTrials.gov record NCT06460805. Inclusion in this directory is not an endorsement.